Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: AIDS. 2022 Apr 1;36(5):637–646. doi: 10.1097/QAD.0000000000003160

Table 4.

Association between glycemic status and physical function in men with HIV: results from multivariate linear mixed models

Grip strength Gait speed
Variables Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Age, years −0.206 (−0.269, −0.143) <0.001 −0.003 (−0.004, −0.002) <0.001
Glycemic status
Normal Ref Ref
IFG −0.014 (−0.416, 0.389) 0.946 0.004 (−0.006, 0.015) 0.413
Controlled DM −0.193 (−0.919, 0.533) 0.602 −0.012 (−0.031, 0.006) 0.186
Uncontrolled DM −1.874 (−2.924, −0.824) <0.001 0.006 (−0.020, 0.032) 0.646
Years of ART 0.183 (0.073, 0.293) 0.001 0.002 (−0.000, 0.004) 0.078
HIV medications, cumulative years
AZT −0.097 (−0.220, 0.026) 0.124 −0.005 (−0.007, −0.002) <0.001
DDI −0.227 (−0.445, −0.009) 0.041 −0.002 (−0.006, 0.002) 0.396
d4T −0.020 (−0.233, 0.193) 0.853 −0.003 (−0.007, 0.001) 0.156
EFV −0.026 (−0.143, 0.092) 0.669 0.001 (−0.001, 0.003) 0.353
Any PI 0.011 (−0.099, 0.122) 0.839 0.002 (−0.000, 0.004) 0.055
CD4 nadir
<200 Ref Ref
200-500 0.341 (−0.874, 1.557) 0.582 0.016 (−0.006, 0.038) 0.160
>500 1.440 (−0.179, 3.060) 0.081 0.016 (−0.014, 0.045) 0.308
Suppressed HIV viral load 0.068 (−0.602, 0.737) 0.843 −0.006 (−0.023, 0.011) 0.490

Models were adjusted for all variables listed in table 3.